Marksans Pharma Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

01:22 PM, 19th May 2025

Marksans Pharma Limiteds wholly owned subsidiary in UK Relonchem Limited received Marketing Authorisation for product Snnosides 7.5 mg tablets